Pharmaceuticals

Surge In Childbirth Rates Fuels Growth Of Pertussis Vaccine Market Is Supporting Development Across The Pertussis Vaccine Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Pertussis Vaccine Market In 2026 And 2030?

The pertussis vaccine market size has consistently increased in recent years. This market is projected to expand from $5.65 billion in 2025 to $5.82 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 2.9%. The growth observed in the historic period can be attributed to high childhood immunization coverage, government-led national vaccination programs, historical outbreaks of whooping cough, the inclusion of the pertussis vaccine in routine immunization schedules, and the availability of whole-cell vaccines.

The pertussis vaccine market is anticipated to experience consistent expansion over the upcoming years. Its value is projected to reach $6.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.1%. This growth during the forecast period stems from factors such as increasing awareness regarding adult pertussis vaccination, growing recommendations for maternal immunization, improvements in vaccine safety and effectiveness, broader access to healthcare in developing economies, and increased development of combination vaccines. Key trends identified for the forecast timeframe encompass the increasing acceptance of acellular pertussis vaccines, a greater emphasis on booster immunization campaigns, the proliferation of combination vaccines incorporating pertussis, the expanding scope of adult and maternal pertussis vaccination, and more robust government immunization efforts.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which Strategic Drivers Are Supporting The Pertussis Vaccine Market Development?

The expanding number of births is propelling the growth of the pertussis vaccine market in the foreseeable future. Childbirth refers to the process of a mother delivering a baby, marking the conclusion of pregnancy where the fetus develops within the womb and signals the start of life outside it. This vaccine is mainly administered to children, offering protection against whooping cough and other serious, potentially fatal illnesses. As an illustration, the United States experienced a 1% rise in recorded births, reaching 3,664,292, in January 2023 compared to 2022, as reported by the Centers for Disease Control and Prevention, a US-based national public health organization. Consequently, the increasing childbirth figures are a key factor stimulating the expansion of the pertussis vaccine market.

What Are The Major Segment Categories Within The Pertussis Vaccine Market?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

What Trends Are Impacting The Pertussis Vaccine Market?

Key companies operating in the pertussis vaccine market are focused on developing improved immunization solutions and obtaining regulatory approvals to bolster maternal and infant protection against whooping cough. These efforts are geared towards enhancing vaccine accessibility, expanding their recommended use during pregnancy, and reducing pertussis-related illness in newborns. For example, in January 2023, the France-based biopharmaceutical company Sanofi S.A. received U.S. FDA approval for the expanded use of its Adacel (Tdap) vaccine during the third trimester of pregnancy. This approval facilitates maternal immunization to help protect infants younger than two months, who are at the highest risk of severe pertussis infection. As a result, healthcare providers can actively immunize pregnant individuals, ensuring that protective antibodies are transferred to the newborn before birth. This provides infants with vital early-life protection against pertussis, bridging the immunity gap until they are able to receive their own vaccinations.

Which Companies Are Engaged In The Pertussis Vaccine Market Environment?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Sanofi Pasteur SA, CSL Limited, Serum Institute of India, Biological E. Limited, Bharat Biotech International Limited, Panacea Biotec Limited, PT Bio Farma, Walvax Biotechnology Co. Ltd., Beijing Minhai Biotechnology Co. Ltd., Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Chiron Corporation, Sinovac Biotech Ltd., Takeda Pharmaceutical Company, Novartis AG, Johnson & Johnson

Access The Complete Pertussis Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Region Is The Primary Market For The Pertussis Vaccine Market?

North America was the largest region in the pertussis vaccine market in 2025. The regions covered in the pertussis vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pertussis Vaccine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Browse Through More Reports Similar to the Global Pertussis Vaccine Market 2026, By The Business Research Company

Pertussis Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Porcine Epidemic Diarrhea Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795